3 results
Cohorts 1, 2, and 3 only:The purpose of this study is to evaluate the overall complete response (CR) rate in participants treated with TAR-200 in combination with cetrelimab (Cohort 1), or TAR-200 alone (Cohort 2), or cetrelimab alone (Cohort 3)…
We hypothesize that a significant proportion of the patients will benefit more from focal therapy as compared to usual care in terms of morbidity and quality of life, without compromising oncological effectiveness. Primary objective: To study the…
- Primary: Determine safety and feasibility of immuno-OCT in vivo imaging with the tracer Bevacizumab-800CW. - Secondary: Validate the immuno-OCT endoscopy system based on:o Fluorescence molecular endoscopy;o Ex vivo fluorescence imaging; o Ex vivo…